Abstract:Obesity is a risk factor for severe disease and mortality for both influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. While previous studies show that individuals with obesity generate antibody responses following influenza vaccination, infection rates within the obese group were twice as high as those in the healthy-weight group. The repertoire of antibodies raised against influenza viruses following previous vaccinations and/or natural exposures is referred to here as baseline immune history (BIH). To investigate the hypothesis that obesity impacts immune memory to infections and vaccines, we profiled the BIH of obese and healthy-weight adults vaccinated with the 2010-2011 seasonal influenza vaccine in response to conformational and linear antigens. Despite the extensive heterogeneity of the BIH profiles in both groups, there were striking differences between obese and healthy subjects, especially with regard to A/H1N1 strains and the 2009 pandemic virus (Cal09). Individuals with obesity had lower IgG and IgA magnitude and breadth for a panel of A/H1N1 whole viruses and hemagglutinin proteins from 1933 to 2009 but increased IgG magnitude and breadth for linear peptides from the Cal09 H1 and N1 proteins. Age was also associated with A/H1N1 BIH, with young individuals with obesity being more likely to have reduced A/H1N1 BIH. We found that individuals with low IgG BIH had significantly lower neutralizing antibody titers than individuals with high IgG BIH. Taken together, our findings suggest that increased susceptibility of obese participants to influenza infection may be mediated in part by obesity-associated differences in the memory B-cell repertoire, which cannot be ameliorated by current seasonal vaccination regimens. Overall, these data have vital implications for the next generation of influenza virus and SARS-CoV-2 vaccines. IMPORTANCE Obesity is associated with increased morbidity and mortality from influenza and SARS-CoV-2 infection. While vaccination is the most effective strategy for preventing influenza virus infection, our previous studies showed that influenza vaccines fail to provide optimal protection in obese individuals despite reaching canonical correlates of protection. Here, we show that obesity may impair immune history in humans and cannot be overcome by seasonal vaccination, especially in younger individuals with decreased lifetime exposure to infections and seasonal vaccines. Low baseline immune history is associated with decreased protective antibody responses. Obesity potentially handicaps overall responses to vaccination, biasing it toward responses to linear epitopes, which may reduce protective capacity. Taken together, our data suggest that young obese individuals are at an increased risk of reduced protection by vaccination, likely due to altered immune history biased toward nonprotective antibody responses. Given the worldwide obesity epidemic coupled with seasonal respiratory virus infections and the inevitable next pandemic, it is imperative that we understand and improve vaccine efficacy in this high-risk population. The design, development, and usage of vaccines for and in obese individuals may need critical evaluation, and immune history should be considered an alternate correlate of protection in future vaccine clinical trials.

The Metabolic Hormone Leptin Promotes the Function of TFH Cells and Supports Vaccine Responses

Leptin Receptor Deficiency Impairs Lymph Node Development and Adaptive Immune Response

Obesity, Rather Than Fat Content Of Diet, Contributes To Reduced Influenza Vaccine Efficacy In Mice Fed A High Fat Diet

Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression

Targeting TFH Cells in Human Diseases and Vaccination: Rationale and Practice

Association of Single Nucleotide Polymorphisms in <i>LEP</i>, <i>LEPR,</i> and <i>PPARG</i> With Humoral Immune Response to Influenza Vaccine

Multicohort analysis reveals baseline transcriptional predictors of influenza vaccination responses

T follicular helper 17 (Tfh17) cells are superior for immunological memory maintenance.

Type 17 Follicular Helper T (Tfh17) Cells are Superior for Memory Maintenance

Interleukin 38 reduces antigen-presentation capacity and antibody production after vaccination

Progress in the role of leptin in immune response

Influenza vaccination stimulates maturation of the human T follicular helper cell response

Recombinant methionyl human leptin administration activates signal transducer and activator of transcription 3 signaling in peripheral blood mononuclear cells in vivo and regulates soluble tumor necrosis factor-alpha receptor levels in humans with relative leptin deficiency

Baseline Circulating Activated TFH and Tissue-Like Exhausted B Cells Negatively Correlate With Meningococcal C Conjugate Vaccine Induced Antibodies in HIV-Infected Individuals

Heme oxygenase‐1 regulates the immune response to influenza virus infection and vaccination in aged mice

The response to influenza vaccination is associated with DNA methylation-driven regulation of T cell innate antiviral pathways

Transcriptomic Analysis Reveals Sixteen Potential Genes Associated with the Successful Differentiation of Antibody-Secreting Cells through the Utilization of Unfolded Protein Response Mechanisms in Robust Responders to the Influenza Vaccine

Obesity Is Associated with an Impaired Baseline Repertoire of Anti-Influenza Virus Antibodies

Influence of Environmental Exposures on T Follicular Helper Cell Function and Implications on Immunity: a comparison of Bangladeshi and American Children

Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine.

Systemic dysregulation and molecular insights into poor influenza vaccine response in the aging population